Trusted by the world’s leading institutions

clients clients clients clients clients clients clients clients clients clients clients
Newswise: Project Could Transform Clinical Trials for Pediatric Brain Tumors
Released: 13-May-2024 6:05 AM EDT
Project Could Transform Clinical Trials for Pediatric Brain Tumors
Children's Hospital Los Angeles

Randomized controlled trials have long been the gold standard for evaluating new therapies. But for pediatric brain tumors, it can be difficult—if not impossible—to enroll the large numbers of patients needed for these studies.

Newswise: Rethinking Ripening: Ethylene's Expanded Role in Strawberry Fruit Development and Maturation
Release date: 13-May-2024 5:05 AM EDT
Rethinking Ripening: Ethylene's Expanded Role in Strawberry Fruit Development and Maturation
Chinese Academy of Sciences

A research team has discovered a potential role for ethylene in the maturation of strawberry fruits, specifically the true fruit—achenes—embedded in the fleshy receptacle.

Newswise: Advancing Fruit Crop Resilience: Unveiling the Molecular Dynamics of Abscission in Woody Fruit Crops
Release date: 13-May-2024 5:05 AM EDT
Advancing Fruit Crop Resilience: Unveiling the Molecular Dynamics of Abscission in Woody Fruit Crops
Chinese Academy of Sciences

A research team has made significant strides in understanding the mechanisms of fruit abscission in woody fruit crops, an essential process affecting fruit yield and economic value.

Newswise: Enhancing Loquat Fruit Quality with Methyl Jasmonate: A Study on Sugar Metabolism and Gene Expression Dynamics
Release date: 13-May-2024 5:05 AM EDT
Enhancing Loquat Fruit Quality with Methyl Jasmonate: A Study on Sugar Metabolism and Gene Expression Dynamics
Chinese Academy of Sciences

A research team investigated the dynamics of soluble sugars in 'Zaozhong 6' loquat fruits following treatment with methyl jasmonate (MeJA).

Not for public release

This news release is embargoed until 13-May-2024 5:00 AM EDT Released to reporters: 10-May-2024 1:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: When and How to Conduct Health Technology Assessments for Biosimilars?
Released: 13-May-2024 4:05 AM EDT
When and How to Conduct Health Technology Assessments for Biosimilars?
ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR announced the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer guidance on when and how to conduct health technology assessments (HTAs) for biosimilars.

Newswise:Video Embedded kitech-develops-deformable-energy-storage-device-via-laser-technology
VIDEO
Released: 13-May-2024 12:00 AM EDT
KITECH Develops Deformable Energy Storage Device via Laser Technology
National Research Council of Science and Technology

The joint research team, led by Dr. Chanwoo Yang and Researcher Seong Ju Park from Korea Institute of Industrial Technology(KITECH), along with Prof. Jin Kon Kim and Dr. Keon-Woo Kim from POSTECH, has successfully developed a compact energy storage device with excellent elasticity.

Newswise: Turning the page on children’s pain
Released: 12-May-2024 10:05 PM EDT
Turning the page on children’s pain
University of South Australia

A new study from the University of South Australia shows how young children learn about the concept of pain through reading, and it’s helping to promote children’s empathy, emotional development, and understand socio-cultural norms.

Newswise: Variations in “ancient” immune cells linked to patients’ survival in cancer
Released: 12-May-2024 9:05 PM EDT
Variations in “ancient” immune cells linked to patients’ survival in cancer
National University of Singapore (NUS)

Researchers from the Cancer Science Institute of Singapore (CSI) at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).

8-May-2024 6:05 AM EDT
World-first regulations to combat sedentary behaviour among children in China show global promise
University of Bristol

Pioneering measures to tackle sedentary behaviour among children in China have proved effective, according to new research.


close
2.29109